Novanta Inc. (NOVT) Guidance & Earnings Results

On 2026-08-05 Novanta Inc. raised guidance: "Q3 2026 revenue $300-304M (>21% growth); adjusted EBITDA $74-77M; adjusted diluted EPS $0.95-1.00. FY2026 revenue $1,130-1,140M (>15% growth); adjusted EBITDA $273-278M (>24% growth); adjusted diluted EPS $3.68-3.74…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason

NOVTNovanta Inc.Follow NOVT — free

Scientific & Technical Instruments · Technology

—

Price chart with a free account

Market cap: 5.3B
P/E TTM: 89.7
Dividend yield: —
52-week: —
Next earnings: 9 Nov, in 16 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
5 Aug 26	Raised	Q3 2026 revenue $300-304M (>21% growth); adjusted EBITDA $74-77M; adjusted diluted EPS $0.95-1.00. FY2026 revenue $1,130-1,140M (>15% growth); adjusted EBITDA $273-278M (>24% growth); adjusted diluted EPS $3.68-3.74 (>12% growth). · full year
11 May 26	Raised	Q2 2026 GAAP revenue $259-264M; Adj. EBITDA $58-62M; Adj. EPS $0.81-0.86. FY26 GAAP revenue $1,040-1,055M; Adj. EBITDA $245-250M; Adj. EPS $3.50-3.65. Q2 organic growth 6-8% (vs Q1 organic 3.1%).
23 Feb 26	Raised	FY2026 revenue guidance $1.03-1.05B vs FY2025 $981M; Adj. EBITDA $245-250M vs $221M; Adj. EPS $3.50-3.65 vs $3.29
3 Nov 25	Raised	Q4 revenue $253M-$257M; FY2025 revenue $975M-$979M
5 Aug 25	Reaffirmed	FY2025 revenue $970-985M; adj. EBITDA $225-230M; adj. EPS $3.22-3.36. Q3 2025 revenue $244-247M; adj. EBITDA $57-60M; adj. EPS $0.78-0.85. · full year

Novanta Inc. — questions

What guidance did Novanta Inc. give?: On 2026-08-05: "Q3 2026 revenue $300-304M (>21% growth); adjusted EBITDA $74-77M; adjusted diluted EPS $0.95-1.00. FY2026 revenue $1,130-1,140M (>15% growth); adjusted EBITDA $273-278M (>24% growth); adjusted diluted EPS $3.68-3.74 (>12% growth)."
When does Novanta Inc. report earnings?: Novanta Inc.'s next earnings report is expected on 2026-11-09.

Every figure on this page comes from Novanta Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.